Diabetes drug in short supply in U.S. after celebrities, influencers touted its weight-loss benefits – CTV

Dec. 14, 2022

Ozempic, a drug used to treat Type 2 diabetes, is extremely hard to find in the U.S., after some celebrities and social media influencers touted it as a weight loss solution.

The drug, also known as semaglutide, was approved in 2017 by the U.S. Food and Drug Administration (FDA), mainly to treat diabetes but it also showed weight loss results. Both Ozempic and Wegovy, another semaglutide medication produced by drug manufacturer Novo Nordisk, were also subsequently approved by Health Canada.

In recent months prominent figures like Elon Musk have said they use the semaglutide medications for weight loss.

But while the FDA has reported an Ozempic shortage in the U.S., the Drug Shortages Canada website has not reported any shortages here.

Read more: https://www.ctvnews.ca/health/diabetes-drug-in-short-supply-in-u-s-after-celebrities-influencers-touted-its-weight-loss-benefits-1.6193064

NationTalk Partners & Sponsors Learn More